Literature DB >> 9261344

Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding.

X Yi1, J Peterson, R Freund.   

Abstract

Polyomavirus middle T antigen is phosphorylated on several tyrosine residues which act as binding sites for cellular proteins, including phosphatidylinositol 3-kinase, Shc, and phospholipase C-gamma. In this report we describe the transforming properties and tumor-inducing ability of a polyomavirus that contains a single-site mutation in middle T antigen which changes a tyrosine residue at amino acid position 250 to serine. This mutation disrupts the association of middle T with the transforming protein Shc. The mutant virus is weakly transforming, inducing foci which are smaller and of different morphology than those of the wild type. Although the virus induced tumors in close to 100% of inoculated mice, the spectrum of tumors and their morphology were altered compared to those of wild-type virus. The mutant virus induced a reduced frequency of kidney and thymic tumors. Both the mammary gland and the thymic tumors that were induced were histologically distinct from those induced by wild-type polyomavirus. These results demonstrate that the signal transduction pathway that is deregulated by the middle T-Shc association is important for full transformation of cells in culture and for tumor induction in some target tissues in the mouse-polyomavirus system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261344      PMCID: PMC191900     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen.

Authors:  J Dahl; U Thathamangalam; R Freund; T L Benjamin
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

2.  Studies of parotid-tumor agent in cultures of leukemic tissues of mice.

Authors:  C J DAWE; L W LAW; T B DUNN
Journal:  J Natl Cancer Inst       Date:  1959-10       Impact factor: 13.506

3.  Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization.

Authors:  A Larose; N Dyson; M Sullivan; E Harlow; M Bastin
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Genetic and structural analysis of a virulence determinant in polyomavirus VP1.

Authors:  P H Bauer; R T Bronson; S C Fung; R Freund; T Stehle; S C Harrison; T L Benjamin
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling.

Authors:  N Li; A Batzer; R Daly; V Yajnik; E Skolnik; P Chardin; D Bar-Sagi; B Margolis; J Schlessinger
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

6.  Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation.

Authors:  G G Carmichael; B S Schaffhausen; D I Dorsky; D B Oliver; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Duplication of noncoding sequences in polyomavirus specifically augments the development of thymic tumors in mice.

Authors:  R Freund; C J Dawe; T L Benjamin
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

8.  Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.

Authors:  J B Bolen; C J Thiele; M A Israel; W Yonemoto; L A Lipsich; J S Brugge
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

9.  A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors.

Authors:  P Blaikie; D Immanuel; J Wu; N Li; V Yajnik; B Margolis
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

10.  Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles.

Authors:  C J Dawe; R Freund; G Mandel; K Ballmer-Hofer; D A Talmage; T L Benjamin
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

View more
  10 in total

1.  Induction of polyomavirus-specific CD8(+) T lymphocytes by distinct dendritic cell subpopulations.

Authors:  D R Drake; M L Shawver; A Hadley; E Butz; C Maliszewski; A E Lukacher
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

3.  Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A.

Authors:  K P Mullane; M Ratnofsky; X Culleré; B Schaffhausen
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

4.  A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.

Authors:  Deborah Denis; Cecile Rouleau; Brian S Schaffhausen
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

5.  Polyomavirus-infected dendritic cells induce antiviral CD8(+) T lymphocytes.

Authors:  D R Drake; J M Moser; A Hadley; J D Altman; C Maliszewski; E Butz; A E Lukacher
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Serine 257 phosphorylation regulates association of polyomavirus middle T antigen with 14-3-3 proteins.

Authors:  X Culleré; P Rose; U Thathamangalam; A Chatterjee; K P Mullane; D C Pallas; T L Benjamin; T M Roberts; B S Schaffhausen
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.

Authors:  M A Webster; J N Hutchinson; M J Rauh; S K Muthuswamy; M Anton; C G Tortorice; R D Cardiff; F L Graham; J A Hassell; W J Muller
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

8.  Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells.

Authors:  Kerry A Whalen; Georg F Weber; Thomas L Benjamin; Brian S Schaffhausen
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

9.  The p110alpha isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation.

Authors:  Tamara Utermark; Brian S Schaffhausen; Thomas M Roberts; Jean J Zhao
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

Review 10.  Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer.

Authors:  Brian S Schaffhausen; Thomas M Roberts
Journal:  Virology       Date:  2008-11-20       Impact factor: 3.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.